Physician profile
Brian Stisser
NPI 1043461064
$7,576.96
in general payments reported to CMS, 2019-2025
50 companies · $753 in 2025
The $753 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,020 · 2020: $540 · 2021: $1,193 · 2022: $1,516 · 2023: $1,339 · 2024: $1,217 · 2025: $753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,292 · Entertainment: $16.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,292.28 |
| Entertainment | $16.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $899.95 | 2019-2025 | Spaceoar Vue System - 10ml, Axonics, Moses 550 D\F\L |
| Astellas Pharma US INC | $719.61 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $682.46 | 2019-2025 | Provenge |
| Teleflex LLC | $478.40 | 2020-2024 | Urolift |
| Intuitive Surgical, INC. | $370.88 | 2019-2023 | Da Vinci Surgical System |
| Edap Technomed INC | $336.00 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $296.48 | 2021-2025 | |
| Abbvie INC. | $257.31 | 2019-2025 | Botox, Lupron Depot |
| Coloplast Corp | $251.29 | 2021-2025 | Porges Coloplast, Speedicath |
| Myovant Sciences INC. | $248.47 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $221.08 | 2023-2024 | Orgovyx, Gemtesa |
| Blue Earth Diagnostics | $205.24 | 2019-2023 | |
| Pfizer INC. | $202.22 | 2019-2022 | |
| Olympus America INC. | $170.97 | 2019-2021 | |
| Karl Storz Endoscopy-America | $166.77 | 2020-2024 | N.A. |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $157.36 | 2020-2024 | Axonics |
| Urogen Pharma, INC. | $153.81 | 2023-2025 | Jelmyto |
| Photocure INC | $133.20 | 2019-2025 | Cysview |
| Janssen Biotech, INC. | $131.96 | 2022-2025 | Erleada |
| Dornier Medtech America, INC | $130.64 | 2023 | Dornier Medtech |
| Endo USA, INC. | $110.19 | 2024-2025 | Xiaflex, Aveed |
| Palette Life Sciences, INC. | $103.76 | 2022 | |
| Allergan, INC. | $99.10 | 2020-2021 | |
| Endo Pharmaceuticals INC. | $85.49 | 2019-2023 | Aveed, Xiaflex |
| Urovant Sciences INC | $80.93 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $71.48 | 2021-2024 | Keytruda, Lynparza, Welireg |
| C. R. Bard, INC. & Subsidiaries | $66.21 | 2021-2024 | |
| Ambu INC. | $61.37 | 2020-2025 | |
| Ferring Pharmaceuticals INC. | $61.04 | 2019-2025 | Adstiladrin |
| Accord Healthcare, INC. | $54.86 | 2023-2024 | |
| Progenics Pharmaceuticals, INC. | $48.96 | 2022 | |
| Myriad Genetic Laboratories, INC. | $44.52 | 2021-2023 | Prolaris |
| Cook Medical LLC | $42.18 | 2021-2023 | Fiber Dust |
| Medtronic, INC. | $39.34 | 2025 | Interstim, Minimed 780g |
| Ge Healthcare | $37.40 | 2025 | |
| Smith+Nephew, INC. | $36.19 | 2020-2021 | |
| Tolmar Pharmaceuticals, INC. | $31.36 | 2019-2020 | |
| Medtronic USA, INC. | $31.15 | 2019 | |
| Rochester Medical Corporation | $29.44 | 2019-2022 | |
| Baxter Healthcare | $28.05 | 2023 | Floseal |
| Laborie Medical Technologies Corp. | $27.94 | 2022 | |
| Tempus Ai, INC | $25.91 | 2025 | Xt Cdx |
| Procept Biorobotics Corporation | $23.00 | 2023 | Aquabeam Robotic System |
| Tolmar, INC. | $22.46 | 2024 | |
| Antares Pharma, INC. | $21.22 | 2022 | |
| 180 Medical, INC. | $17.02 | 2019 | |
| Provepharm INC. | $16.45 | 2024 | Bludigo |
| E.R. Squibb & Sons, L.L.C. | $16.00 | 2022 | |
| Neotract INC. | $15.73 | 2019 | |
| Emd Serono, INC. | $14.11 | 2023 | Bavencio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Stisser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.